Lantern Pharma Inc. (LTRN): Price and Financial Metrics
LTRN Price/Volume Stats
| Current price | $2.94 | 52-week high | $11.99 |
| Prev. close | $3.08 | 52-week low | $2.90 |
| Day low | $2.90 | Volume | 71,700 |
| Day high | $3.19 | Avg. volume | 131,526 |
| 50-day MA | $3.57 | Dividend yield | N/A |
| 200-day MA | $4.96 | Market Cap | 31.71M |
LTRN Stock Price Chart Interactive Chart >
Lantern Pharma Inc. (LTRN) Company Bio
Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-11, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.
LTRN Price Returns
| 1-mo | -13.27% |
| 3-mo | -36.77% |
| 6-mo | -53.11% |
| 1-year | -26.32% |
| 3-year | -66.70% |
| 5-year | N/A |
| YTD | -31.31% |
| 2023 | -29.14% |
| 2022 | -24.31% |
| 2021 | -58.55% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...